Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients

The significance of cancer stem cells (CSCs) in initiation and progression of colon cancer (CC) has been established. In this study, we investigated the utility of measuring mRNA expression levels of CSC markers EpCAM, LGR5 and LGR4 for predicting survival outcome in surgically treated CC patients....

Full description

Bibliographic Details
Main Authors: Manar AbdelMageed, Hager Tarek H. Ismail, Lina Olsson, Gudrun Lindmark, Marie-Louise Hammarström, Sten Hammarström, Basel Sitohy
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/1/403
_version_ 1797498794694148096
author Manar AbdelMageed
Hager Tarek H. Ismail
Lina Olsson
Gudrun Lindmark
Marie-Louise Hammarström
Sten Hammarström
Basel Sitohy
author_facet Manar AbdelMageed
Hager Tarek H. Ismail
Lina Olsson
Gudrun Lindmark
Marie-Louise Hammarström
Sten Hammarström
Basel Sitohy
author_sort Manar AbdelMageed
collection DOAJ
description The significance of cancer stem cells (CSCs) in initiation and progression of colon cancer (CC) has been established. In this study, we investigated the utility of measuring mRNA expression levels of CSC markers EpCAM, LGR5 and LGR4 for predicting survival outcome in surgically treated CC patients. Expression levels were determined in 5 CC cell lines, 66 primary CC tumors and 382 regional lymph nodes of 121 CC patients. Prognostic relevance was determined using Kaplan-Meier survival and Cox regression analyses. CC patients with lymph nodes expressing high levels of EpCAM, LGR5 or LGR4 (higher than a clinical cutoff of 0.07, 0.06 and 2.558 mRNA copies/18S rRNA unit, respectively) had a decreased mean survival time of 32 months for EpCAM and 42 months for both LGR5 and LGR4 at a 12-year follow-up (<i>p</i> = 0.022, <i>p</i> = 0.005 and <i>p</i> = 0.011, respectively). Additional patients at risk for recurrence were detected when LGR5 was combined with the biomarkers CXCL17 or CEA plus CXCL16. In conclusion, the study underscores LGR5 as a particularly useful prognostic biomarker and illustrates the strength of combining biomarkers detecting different subpopulations of cancer cells and/or cells in the tumor microenvironment for predicting recurrence.
first_indexed 2024-03-10T03:38:29Z
format Article
id doaj.art-4595bbded33a4b129a5da325a389d721
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T03:38:29Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4595bbded33a4b129a5da325a389d7212023-11-23T11:39:28ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0123140310.3390/ijms23010403Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer PatientsManar AbdelMageed0Hager Tarek H. Ismail1Lina Olsson2Gudrun Lindmark3Marie-Louise Hammarström4Sten Hammarström5Basel Sitohy6Department of Clinical Microbiology, Infection and Immunology, Umeå University, SE-90185 Umeå, SwedenDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, SE-90185 Umeå, SwedenDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, SE-90185 Umeå, SwedenInstitution of Clinical Sciences, Lund University, SE-25187 Helsingborg, SwedenDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, SE-90185 Umeå, SwedenDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, SE-90185 Umeå, SwedenDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, SE-90185 Umeå, SwedenThe significance of cancer stem cells (CSCs) in initiation and progression of colon cancer (CC) has been established. In this study, we investigated the utility of measuring mRNA expression levels of CSC markers EpCAM, LGR5 and LGR4 for predicting survival outcome in surgically treated CC patients. Expression levels were determined in 5 CC cell lines, 66 primary CC tumors and 382 regional lymph nodes of 121 CC patients. Prognostic relevance was determined using Kaplan-Meier survival and Cox regression analyses. CC patients with lymph nodes expressing high levels of EpCAM, LGR5 or LGR4 (higher than a clinical cutoff of 0.07, 0.06 and 2.558 mRNA copies/18S rRNA unit, respectively) had a decreased mean survival time of 32 months for EpCAM and 42 months for both LGR5 and LGR4 at a 12-year follow-up (<i>p</i> = 0.022, <i>p</i> = 0.005 and <i>p</i> = 0.011, respectively). Additional patients at risk for recurrence were detected when LGR5 was combined with the biomarkers CXCL17 or CEA plus CXCL16. In conclusion, the study underscores LGR5 as a particularly useful prognostic biomarker and illustrates the strength of combining biomarkers detecting different subpopulations of cancer cells and/or cells in the tumor microenvironment for predicting recurrence.https://www.mdpi.com/1422-0067/23/1/403colon cancerEpCAMLGR5LGR4CEACXCL17
spellingShingle Manar AbdelMageed
Hager Tarek H. Ismail
Lina Olsson
Gudrun Lindmark
Marie-Louise Hammarström
Sten Hammarström
Basel Sitohy
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
International Journal of Molecular Sciences
colon cancer
EpCAM
LGR5
LGR4
CEA
CXCL17
title Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
title_full Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
title_fullStr Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
title_full_unstemmed Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
title_short Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
title_sort clinical significance of stem cell biomarkers epcam lgr5 and lgr4 mrna levels in lymph nodes of colon cancer patients
topic colon cancer
EpCAM
LGR5
LGR4
CEA
CXCL17
url https://www.mdpi.com/1422-0067/23/1/403
work_keys_str_mv AT manarabdelmageed clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients
AT hagertarekhismail clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients
AT linaolsson clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients
AT gudrunlindmark clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients
AT marielouisehammarstrom clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients
AT stenhammarstrom clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients
AT baselsitohy clinicalsignificanceofstemcellbiomarkersepcamlgr5andlgr4mrnalevelsinlymphnodesofcoloncancerpatients